Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intrauterine hCG before frozen embryo transfer
NCT02355925Phase 3Completed
- Sponsor
- Royan Institute
- Start
- Oct 2014
- Primary completion
- Dec 2018
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of human chorionic gonadotropin in infertility (3 arms), sponsored by Royan Institute. Primary endpoint: Clinical pregnancy rate at 4 weeks. Started Oct 2014; status: completed.
02
Drugs
human chorionic gonadotropin
03
Conditions
infertility
Beyond the preview
Go deeper on NCT02355925.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02355925.